Stocks to invest in – Gilead Sciences, Inc. (GILD) Is A Hail Mary: 3 Better Stocks To Consider

Stocks to invest in


Gilead Sciences, Inc. (NASDAQ:GILD) is a research-based biopharmaceutical company. It has several blockbuster drugs within its two largest product lines that treat hepatitis (Harvoni and Sovaldi) and HIV/AIDS (Truvada and Altripa). Impressively, the company has a large profit margin (close to 50%), it offers an attractive 2.6% dividend yield, and its dividend payout ratio is amazingly low at only 16.4%. However, growth is slowing and competition is beginning to creep in. Specifically, Gilead will experience a couple big patent expirations in 2018 and 2021, generic competition is on its way, and revenues are already declining as shown in the following chart.


– Stocks to invest in

Learn How To Be #1 on Google Results

Source link